EnerFlex D-DIET reverses liver inflammation in type 2 diabetes

Patient Profile:

Chinese, Male. Malaysia
Date of Birth: 27/9/1940

The History:

Patient was initially suffering from severe and recurrent fever and flu in early November 2001 He was then diagnosed by Gastroentorologist & Physician suffering acute liver inflammation and was asked to rest and prescribed milk thistle.His liver function markers (GGT, ALT, AST,Total Bilirubin), LDL-C, Triglyceride, fasting glucose were highly elevated. No drugs were prescribed other than milk thistle. After 2 weeks on the treatment, no improvement were seen. On 20th November, patient was introduced EnerFlex 40g daily.

Although patient back to normal life with EnerFlex, he did not watch his diet despite of having high sugar and HbA1C levels. In June 2007 patient experienced dizziness and was admitted to a General Hospital and anti-diabetic drugs Gliclazide and Metformin were prescribed at maximum dose. Despited of taking the medications for 6 months and restricted diet, patient's diabetes profile remained uncontrolled and he was complaining severe abdominal pain, stomach distention and constipated. He also had recurrent fever. His liver GGT above 1000 u/L.

EnerFlex Saves Patient's Life Twice with Liver Inflammation

Beware of potential side effects on1 liver function of combined use of anti-diabetic drugs: gliclazide and metformin!

Started EnerFlex 40g daily on 20.11.2001 as a result of acute liver hepatitis. Diagnosed hyperlipidemia and hyperglycemia. Patient was non-alcoholic.

1st he was saved by EnerFlex...

After 1 week on EnerFlex 40g daily, patient was fully recovered and back to normal life although his GGT was still elevated. Initiated 20g AFA daily + 40g EnerFlex daily on Jan 03 with the objective to help rejuvenate his liver. Switched to EnerFlex Combo 40g BID on 26/10/04 to help reduce his central obesity with the hope to reduce risk of metabolic syndrome. Patient worried about the power of slimming of EnerFlex COMBO and decided to switch to other EnerFlex range. Switched to EnerFlex Forte 40 g + EnerrFlex 40g daily on Jan 05. Switched to EnerFlex PROCARDO as user worry about getting slimmer in Dec 06. In December 2006, patient stopped EnerFlex PROCARDO as advised by his Chinese Physician that soy it's not good for his kidney function. Subject did not control strictly on high glycemix index and saturated fat diet.

Then, he was saved by EnerFlex PROBIOTIC and AFA

Sometime in June 2007, patient complained dizziness and was admitted to Sg. Buloh General Hospital and his blood glucose was 23 mmol/L. Patient was prescribed 80mg Gliclazide and 400mg metformin BID daily due to his uncontrolled glucose level. Patient was feeling better after 1 week on the medications. After 5 months on the medications, patient was complaining stomach and abdominal distention, difficulty to urinate and poor bowel movement (constipated), fatigue, swollen face and lower extremities. Rashes and itchiness around arms, chest and abdomen with recurrent fever and was admitted to University Hospital on 26.11.07 for thorough check up. It was found his liver GGT shot up to 1168u/L with hyperlipidemia with his glucose level of 19mmol/L.He was then advised for a CT Scan to access the possibility of stomach/liver cancer .Gliclazide and Metformin were continued at maximum doses. Patient also complained about nerve pain/nerve tingling on lower extremities. He began to lose his taste buds. Everything he tasted was bitter. CT Scan on 7 December 2007 reported normal on all organs except suspected liver cirrhosis. Prior to admission, patient was given 2 sachets of EnerFlex PROBIOTIC (taken 3 times daily) and his stomach and abdominal distention were relieved. Patient decided to check out on 27.11.07 to prepare for his son's wedding on 3.12.07. Looking at the patient's situation and history his son in-law and other family members suspected the side effects of the anti-diabetic drug is the main causal of his problems but was not a concern by the consulting doctors. Since 29.11.07, patient was advised to stop all anti-diabetic drugs and solely on EnerFlex PROBIOTIC 20g and EnerFlex +AFA 20g taken three times daily (before breakfast/ 3-4pm/before bed).

After 1-2 weeks on the remedy, patient felt more energetic, alert and excellent bowel movements. Rashes began to subside too and no more he suffered no more recurrent fever.

After 1 month on the products, blood test revealed a healthier markers for his lipid profile and liver function markers. His GGT dropped from 1168 to 403 u/L. Patient felt good in overall except tingling nerve pain occasionally. No more stomach and abdominal distention. Since 29.11.07 he passes motion 2-3 times daily. His taste buds normalized.

Liver Function Markers

Liver Function Marker

Combination use of EnerFlex +AFA and EnerFlex PROBIOTIC significantly help restore patient's liver function. He felt energetic without anti-diabetic drugs. His liver enzymes were dropping drastically. All got normal except GGT still on a high side and dropped more than half from 1186 u/L after slightly more than a month of product consumptions. His lipid profile was back to normal. After 11 weeks on EnerFlex liver rejuvenation program, patient's liver function markers were all normalized except with elevated GGT but with further reduction trend.

Understand how does EnerFlex+ AFA work

Patient's Biochemistry Profile Since 2001

LIPID PROFILE 20.11.01 3.1.02 15.4.03 28.6.03 18.10.03 16.10.04 6.8.05 23.12.06 31.03.07 29.11.07 4.01.08 16.02.08 Current Ref Range used Ref Range used before Dec 04
ATHEROCLEROSIS STUDY
Total cholesterol, mmol/L 6.3 4.5 5.1 5.8 5.8 4.4 4.0 4.8 5.8 6.4 4.8 5.0 < 5.2 < 5.2
HDL,mmol/L 1.19 0.94 1.16 1.31 1.47 0.91 1.13 1.31 1.57 0.99 0.97 1.22 > 1.03 > 0.90
LDL,mmol/L 4.0 2.7 3.3 3.66 3.60 2.21 1.95 2.66 3.73 4.17 2.87 3.14 < 2.58 < 3.9
Triglycerides,mmol/L 2.50 1.90 1.30 1.80 1.60 2.80 2.00 1.80 1.10 2.70 2.10 1.40 < 1.68 < 2.3
Total/HDL Ratio 5.3 4.8 4.4 4.4 3.9 4.8 3.5 3.7 3.7 6.5 4.9 4.1 < 5.0 < 5.8
When EnerFlex was consumed by patient, lipid profiles were in good control throughout the years. The moment, EnerFlex was stopped in December 2006, his LDL levels were elevated and having indicated that EnerFlex is essential to keep his LDL within normal as possible by regulating his cholesterol metabolism and liver function. In November 2007, his lipid profile was entirely out as a result of suspected liver cirrhosis or adenoma or likely due to anti-diabetic drugs. The mediations were stopped and Enerflex PROBIOTIC 20g and EnerFlex +AFA20g were consumed together 3 times daily, and patient felt much better after 7 days. On February, his overall profile returned to normal. The increase in LDL could be temporarily due to drastic reduction of Triglycerides.
LIVER FUNCTION MARKERS TEST
TOTAL PROTEIN, G/L 78 79   82 84 83 83 76 82 75 83 79 60 - 81  
ALBUMIN, G/L 41 41   43 41 39 44 40 44 38 42 41 35 - 50  
GLOBULIN, G/L 37 38   39 43 44 39 36 38 37 41 38 20 - 39  
A/G RATIO 1.11 1.08   1.10 0.95 0.89 1.13 1.11 1.16 1.03 1.02 1.08 1.0 - 2.5  
TOTAL BILIRUBIN, µmol/L 13 13   17 23 16 23 21 27 30 23 20 < 21  
ALKALINE PHOSPHATASE, U/L 131 127 96 93 88 67 82 100 124 136 119 123 40 - 130  
AST (SGOT), U/L 92 69 49 58 64 45 43 28 26 50 44 32 < 41  
ALT (SGPT), U/L 105 73 66 109 72 67 61 42 33 56 40 36 < 51  
GGT, U/L 305 100 97 216 166 186 198 288 249 1168 403 290 < 51  
When EnerFlex was consumed by patient, liver function markers were manageable. Once it was stopped (between Dec 06 –Mar 07), EnerFlex PROCARDO 40g daily (with 20g dietary fibre daily) were introduced to patient.  GGT was found on the rise. During the administration of anti-diabetic drugs of glyclazide and metformin, patient’s GGT hit 1168u/L with gastrointestinal disorders (constipation, heartburn, and abdomen distention and stomach pain), relapse fever and abnormal taste buds. Patient decided to stop the medications and solely on EnerFlex PROBIOTIC and EnerFlex +AFA 20g each 3 times daily. His gastrointestinal problems resolved within 72 hours. He became more alert and energetic within 7 days.
RENAL FUNCTION MARKER STUDY
UREA, mmol/L 5.8 4.1   4.4 3.3 4.5 4.2 4.9 3.5 2.8 4.3 4.5 3.0 - 9.0  
URIC ACID, mmol/L 0.28 0.27   0.27 0.27 0.26 0.29 0.24 0.23 0.27 0.26 0.28 0.18 - 0.47  
CREATININE, mmol/L 0.078     0.09 0.07 0.07 0.079 0.066 0.063 0.053 0.053 0.057 0.06 - 0.13  
Corrected Calcium, mmol/L 2.33     2.26 2.17 2.3 2.15 2.18 2.21 2.24 2.26 2.28 2.10 - 2.55  
Phosphate, mmol/L       1.15 1.20 1.11 1.09 1.05 1.31 0.89 1.20 1.40 0.65 - 1.45  
Chloride, mmol/L 103     97 100 101 102 101 99 99 97 97 95 - 110  
Sodium, mmol/L 137     136 137 137 138 137 135 137 132 134 135 - 145  
Potassium, mmol/L 3.7     4.4 4.1 4.3 4.2 4.3 4.6 4.4 4.2 4.5 3.5 - 5.1  
Long term consumption of EnerFlex range of products did not impose negative effect on renal function and uric acid levels.
DIABETES PROFILE
FASTING CLUCOSE, mmol/L 9.2   8.4 14.5 7.9 13.5 12.2 15.2 15.8 13.8 16.2 11.9 3.9 - 5.5  
HBA1C, %       11.3 10.4 11.0 11.7 14.4 14.2 9.5 10.2 10.9 < 6%  
In addition to EnerFlex, Insulin was administered into patient 3 times daily beginning 3rd week of January as a result of uncontrolled diabetes profile and his fasting glucose dropped to the lowest as compared to 2006.
DIABETES PROFILE
HEMAGLOBIIN, g/L, 122           122 116 121 112 113 121 130 - 180  
RBC /L, x1012 6.1           6.09 5.69 6.03 5.26 5.65 6.14 4.5 - 6.5  
PCV, L/L 0.38           0.4 0.35 0.37 0.35 0.36 0.39 0.4 - 0.55  
MCV, fL 62           65 61 62 66 64 63 78 - 99  
MCH, pg 20           20 20 20 21 20 20 27 - 32  
MCHC, g/L 320           308 334 324 323 312 313 300 - 360  
RDW, %             16.1 16.0 15.8 17.6 15.0 15.3 11.0 - 15.0  
WHITE CELL COUNT X 109/L             6.4 6.7 8.3 8.1 7.1 9.1 4.0 - 11.0  
Neutrophils X 109/L             2.3 3.4 5.7 3.6 3.9 5.6 2.0 - 8.0  
Lymphocytes X 109/L             3.1 2.8 2.2 3.8 2.6 2.7 1.0 - 4.0  
Monocytes X 109/L             0.5 0.3 0.3 0.4 0.3 0.5 < 1.1  
Eosinophils X 109/L             0.4 0.2 0.0 0.2 0.3 0.2 < 0.6  
Basophils X 109/L             0.1 0.1 0.0 0.1 0.1 0.1 < 0.2  
ESR, mm/H 25           2 10 25 25 5 20 < 26  
Platelet/L X 109 185           175 188 181 286 184 221 150 - 450  
Reported mild anemia. The red cells show moderate hypochromia, moderate microcytosis, mild anisocytosis with poikilocytosis, several target cells, several schistocytes and basophilic stippling. The white cells and platelets appear normal.